| Clinical UM Guideline |
| Subject: Transcutaneous Electrical Nerve Stimulation | |
| Guideline #: CG-DME-04 | Publish Date: 04/15/2026 |
| Status: Reviewed | Last Review Date: 02/19/2026 |
| Description |
This document addresses transcutaneous electrical nerve stimulation (TENS). TENS is used to treat pain by sending electrical impulses through electrodes placed on the skin. These pulses stimulate sensory nerve fibers and are thought to modify pain perception. Other indications for TENS have also been proposed.
Note: Please see the following related documents for additional information:
Note: Over-the-counter (OTC) devices are generally excluded from benefit plan coverage.
Note: For a high-level overview of this document, please see “Summary for Members and Families” below.
| Clinical Indications |
Medically Necessary:
TENS units are considered medically necessary when prescribed as a treatment for pain for those who have not responded to other modalities, in the following situations:
TENS garments are considered medically necessary when:
Not Medically Necessary:
Use of TENS is considered not medically necessary when the above criteria are not met, and for all other indications.
| Summary for Members and Families |
This document describes clinical studies and expert recommendations, and explains the appropriate use of transcutaneous electrical nerve stimulation (TENS), a device that sends electrical pulses through the skin to help reduce pain. The following summary does not replace the medical necessity criteria or other information in this document. The summary may not contain all of the relevant criteria or information. This summary is not medical advice. Please check with your healthcare provider for any advice about your health.
Key Information
TENS units are devices that deliver small electrical pulses through electrodes placed on the skin. These pulses may help block pain signals. TENS can also be used with a special garment instead of skin electrodes when needed. TENS is most often used to help manage pain caused by muscle, bone, or joint problems, or after injuries. While TENS devices are available without a prescription, they may be prescribed when other treatments have not helped. Experts and some medical groups support using TENS as part of a broader approach to managing long-term pain, including the American Society of Anesthesiologists (ASA) and American Society of Regional Anesthesia and Pain Medicine (ASRA). However, research on TENS has mixed results. Some studies suggest it may help in certain cases, but others show limited benefit. Better studies are needed to know if TENS improves health for many conditions.
What the Studies Show
TENS has been studied for many types of pain, including back pain, joint pain, nerve pain, surgery pain, and pain from health conditions such as diabetes or cancer. While some research shows it may help certain kinds of pain, many studies have problems such as unclear results or not enough information about how the treatment was given. This makes it hard to know how well TENS truly works. For example, some studies suggest TENS might help with period pain, multiple sclerosis symptoms, or after joint surgery. But other research found it did not clearly help with issues like migraines, phantom limb pain, or post-surgery healing. More high-quality studies are needed to show when TENS is helpful and safe.
When is TENS Clinically Appropriate?
TENS (transcutaneous electrical nerve stimulation) may be appropriate in these situations:
TENS garments may also be appropriate when:
When is this not Clinically Appropriate?
TENS is not appropriate when the conditions above are not met, or for any other uses. This is because studies have not shown that TENS clearly helps in these other situations. Using unproven or unnecessary treatments can lead to confusion or treatment that does not help.
| Coding |
The following codes for treatments and procedures applicable to this document are included below for informational purposes. Inclusion or exclusion of a procedure, diagnosis or device code(s) does not constitute or imply member coverage or provider reimbursement policy. Please refer to the member's contract benefits in effect at the time of service to determine coverage or non-coverage of these services as it applies to an individual member.
When services may be Medically Necessary when criteria are met:
| HCPCS |
|
| A4595 |
Electrical stimulator supplies, 2 lead, per month (e.g., TENS, NMES) |
| A4630 |
Replacement batteries, medically necessary, transcutaneous electrical stimulator, owned by patient |
| E0720 |
Transcutaneous electrical nerve stimulation (TENS) device, two lead, localized stimulation |
| E0730 |
Transcutaneous electrical nerve stimulation (TENS) device, four or more leads, for multiple nerve stimulation |
| E0731 |
Form-fitting conductive garment for delivery of TENS or NMES (with conductive fibers separated from the patient’s skin by layers of fabric) [when specified for TENS] |
|
|
|
| ICD-10 Diagnosis |
|
|
|
All diagnoses |
When services are Not Medically Necessary:
For the procedure codes listed above when criteria are not met or for all other indications.
| Discussion/General Information |
Summary
Transcutaneous Electrical Nerve Stimulation (TENS) units are considered medically necessary for managing pain associated with musculoskeletal conditions or active/post-trauma injuries when other treatments have failed. TENS garments are also deemed necessary when conventional electrodes cannot be used due to factors like large or inaccessible stimulation areas or certain medical conditions (e.g., skin disorders). TENS is not considered medically necessary when these criteria are not met or for other unapproved uses. While TENS is widely accepted among physicians and supported by professional societies such as the American Society of Anesthesiologists (ASA) and American Society of Regional Anesthesia and Pain Medicine (ASRA) for pain management, many clinical studies on its efficacy suffer from methodological issues, resulting in weak or inconclusive evidence across a broad range of conditions. Nonetheless, some systematic reviews support its use in treating specific conditions such as chronic back pain, dysmenorrhea, pain following total knee arthroplasty, and other indications. TENS devices are also readily available over the counter.
Discussion
TENS units are battery-operated devices that apply electrical stimulation through wired electrodes that are taped to the surface of the skin. TENS can also be delivered through the use of a form-fitting conductive garment (for example, a garment with conductive fibers that are separated from the individual’s skin by layers of fabric). This garment is applied when a condition exists that precludes conventional TENS electrode placement. TENS has been used to relieve pain related to musculoskeletal conditions, or pain associated with active or post-trauma injury.
There are many published reports regarding the use of TENS for various types of conditions such as low back pain (LBP), myofascial and arthritic pain, sympathetically mediated pain, neurogenic pain, visceral pain, diabetic neuropathy and postsurgical pain. While randomized controlled trials (RCTs) have focused on TENS, many of the currently available studies have methodological flaws that limit interpretation or generalizability, including inadequate blinding, lack of reporting of dropouts, lack of reporting of stimulation variables, and lack of proper outcome measures (Johnson, 2015b; Ögren, 2024). However, it is recognized that TENS is widely accepted in the physician community as a treatment of a variety of etiologies of pain.
The ASA and ASRA support the use of TENS in their revised guideline recommending that “TENS should be used as a multimodal approach to pain management for patients with chronic back pain and may be used for other pain conditions (e.g. neck and phantom limb pain)” (ASA/ASRA, 2010).
Several trials, systematic reviews, and meta-analyses have been published evaluating the use of TENS in a variety of potential indications including, but not limited to, bladder discomfort and function (Park, 2024; Tang, 2024; Zhao, 2024), diabetes (Lu, 2023), fibromyalgia (Mattar, 2025), inguinal hernia repair (Parselenes, 2021), knee osteoarthritis (Chen, 2016; Cherian, 2016; Katagiri, 2025 ; Özbaş, 2025; Reichenbach, 2022; Wu 2022; Yamada, 2025), labor pain (Thuvarakan, 2025), long covid (Zulbaran-Rojas 2024), migraine headache (Domingues, 2021; Hokenek, 2021; Tao, 2018), peripheral neuropathy (Ogle, 2020), pelvic pain (Cottrell, 2019), phantom stump pain (Johnson, 2015a), postoperative gastrointestinal recovery (Karthik 2024; Penfold, 2018), postoperative pain (Henkel, 2025; Oksar, 2024; Opolka, 2024; Öztürk, 2024; Sabancı, 2024), restless leg syndrome (Şanli, 2024), rotator cuff injuries (Desmeules, 2016; Mahure, 2017), sickle cell disease (Pal, 2020), spinal cord injury (Harvey, 2016), soft tissue injuries of the elbow (Dion, 2016), temporomandibular joint pain (Busse, 2023; Fertout, 2019; Nemani, 2024, Serrano-Muñoz, 2023), wound infection (Qin, 2024), and xerostomia (Sivaramakrishnan, 2017).The results of these trials revealed weak or inconclusive support for the use of TENS for these indications.
Support for the use of TENS was found in systematic reviews conducted on its application in the treatment of dyspareunia, (Fernández‑Pérez, 2023), in-office and post hysteroscopy (De Silva, 2020; Ghamry, 2020) chronic back pain (Jauregui, 2016), dysmenorrhea (Arik, 2022; Guy, 2023), total knee arthroplasty (Li, 2017; Yue, 2018; Zhu, 2017), multiple sclerosis (Sawant, 2015), post cardiothoracic surgery (Cardinali, 2021), and limb spasticity (Mahmood, 2019; Mills, 2016).
TENS devices are generally available without a prescription (that is, over the counter [OTC]), and they are widely available at a variety of standard and online retail outlets.
| References |
Peer Reviewed Publications:
Government Agency, Medical Society and Other Authoritative Publications:
| Index |
TENS (Transcutaneous Electrical Nerve Stimulation)
Transcutaneous Electrical Nerve Stimulation (TENS)
| History |
| Status |
Date |
Action |
| Reviewed |
02/19/2026 |
Medical Policy & Technology Assessment Committee (MPTAC) review. Added “Summary for Members and Families” section. Revised Description, Discussion/General Information and References sections. |
| Revised |
02/20/2025 |
MPTAC review. Revised title, scope, and all other content of document to remove PENS. Revised TENS garment criteria. Revised formatting in Clinical Indications section. Updated Description, Discussion/General Information, References, and Index sections. |
| Reviewed |
05/09/2024 |
MPTAC review. Updated Discussion/General Information and References sections. |
| Reviewed |
05/11/2023 |
MPTAC review. Updated Discussion/General Information and References sections. |
| Reviewed |
05/12/2022 |
MPTAC review. Updated Discussion/General Information and References sections. |
| Revised |
05/13/2021 |
MPTAC review. Clarified MN statements by removing ‘FDA approved’ language. Updated Discussion/General Information and References sections. Reformatted Coding section. |
| Reviewed |
05/14/2020 |
MPTAC review. Updated Description, Discussion/General Information and References sections. |
| Reviewed |
06/06/2019 |
MPTAC review. Updated Description, Discussion/General Information and References sections. |
| Revised |
07/26/2018 |
MPTAC review. The document header wording updated from “Current Effective Date” to “Publish Date.” Updated Discussion/General Information and References sections. |
| Revised |
08/03/2017 |
MPTAC review. Added a NMN section. Updated Discussion/General Information and References sections. |
| Reviewed |
08/04/2016 |
MPTAC review. Updated Discussion/General Information and References. Removed ICD-9 codes from Coding section. |
| Revised |
08/06/2015 |
MPTAC review. Revised formatting in criteria. Updated Discussion/General Information and References. |
| Reviewed |
08/14/2014 |
MPTAC review. Updated Discussion/General Information and References. |
| Reviewed |
08/08/2013 |
MPTAC review. Updated References. |
| Reviewed |
08/03/2012 |
MPTAC review. Discussion/General Information and References updated. |
| Reviewed |
08/18/2011 |
MPTAC review. Coding and References updated. |
| Reviewed |
08/19/2010 |
MPTAC review. Discussion and References updated. |
| Reviewed |
08/27/2009 |
MPTAC review. References updated. |
| Reviewed |
08/28/2008 |
MPTAC review. References updated. |
| Reviewed |
08/23/2007 |
MPTAC review. References updated. |
|
|
01/01/2007 |
Updated coding section with 01/01/2007 CPT/HCPCS changes. |
| Revised |
09/14/2006 |
MPTAC review. Revision included addressing TENS garment. References updated. |
|
|
11/22/2005 |
Added reference for Centers for Medicare and Medicaid Services (CMS) - National Coverage Determination (NCD). |
| Revised |
09/22/2005 |
MPTAC review. Revisions based on Pre-merger Anthem and Pre-merger WellPoint Harmonization. |
| Pre-Merger Organizations |
Last Review Date |
Document Number |
Title |
| Anthem, Inc. |
|
None |
|
| Anthem BCBS |
|
None |
|
| WellPoint Health Networks, Inc. |
04/28/2005 |
5.10.01 |
Electrical Nerve Stimulation, Transcutaneous, Percutaneous |
Federal and State law, as well as contract language, and Medical Policy take precedence over Clinical UM Guidelines. We reserve the right to review and update Clinical UM Guidelines periodically. Clinical guidelines approved by the Medical Policy & Technology Assessment Committee are available for general adoption by plans or lines of business for consistent review of the medical necessity of services related to the clinical guideline when the plan performs utilization review for the subject. Due to variances in utilization patterns, each plan may choose whether to adopt a particular Clinical UM Guideline. To determine if review is required for this Clinical UM Guideline, please contact the customer service number on the member's card.
Alternatively, commercial or FEP plans or lines of business which determine there is not a need to adopt the guideline to review services generally across all providers delivering services to Plan’s or line of business’s members may instead use the clinical guideline for provider education and/or to review the medical necessity of services for any provider who has been notified that his/her/its claims will be reviewed for medical necessity due to billing practices or claims that are not consistent with other providers, in terms of frequency or in some other manner.
No part of this publication may be reproduced, stored in a retrieval system or transmitted, in any form or by any means, electronic, mechanical, photocopying, or otherwise, without permission from the health plan.
© CPT Only - American Medical Association